Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cleft Lip | 3 | 2023 | 25 | 1.370 |
Why?
|
| Cleft Palate | 3 | 2023 | 41 | 1.350 |
Why?
|
| Prenatal Diagnosis | 3 | 2025 | 40 | 1.180 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2025 | 2 | 0.940 |
Why?
|
| Holoprosencephaly | 1 | 2023 | 2 | 0.820 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 735 | 0.700 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2021 | 7 | 0.680 |
Why?
|
| Intellectual Disability | 5 | 2026 | 176 | 0.630 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2026 | 50 | 0.550 |
Why?
|
| Glycogen Storage Disease Type II | 2 | 2019 | 8 | 0.500 |
Why?
|
| alpha-Glucosidases | 2 | 2019 | 10 | 0.490 |
Why?
|
| Phenotype | 5 | 2021 | 1235 | 0.480 |
Why?
|
| Genetic Association Studies | 5 | 2021 | 120 | 0.380 |
Why?
|
| Pregnancy | 3 | 2025 | 2392 | 0.310 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 54 | 0.310 |
Why?
|
| Mutation | 4 | 2021 | 2670 | 0.290 |
Why?
|
| Loss of Function Mutation | 2 | 2026 | 23 | 0.280 |
Why?
|
| Infant, Newborn | 6 | 2021 | 1437 | 0.260 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2006 | 9 | 0.240 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2006 | 3 | 0.240 |
Why?
|
| Genotype | 4 | 2021 | 674 | 0.240 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 47 | 0.240 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 31 | 0.230 |
Why?
|
| Electron Transport Complex III | 2 | 2021 | 5 | 0.230 |
Why?
|
| Child, Preschool | 8 | 2026 | 2075 | 0.230 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2006 | 52 | 0.230 |
Why?
|
| Female | 16 | 2026 | 34298 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 18 | 0.230 |
Why?
|
| Placenta | 1 | 2025 | 69 | 0.220 |
Why?
|
| Humans | 22 | 2026 | 65635 | 0.220 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 38 | 0.220 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2021 | 29 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2026 | 139 | 0.220 |
Why?
|
| Tay-Sachs Disease | 1 | 2025 | 55 | 0.210 |
Why?
|
| Infant | 8 | 2025 | 1711 | 0.210 |
Why?
|
| Hand Deformities, Congenital | 1 | 2023 | 4 | 0.200 |
Why?
|
| Amniocentesis | 1 | 2023 | 6 | 0.200 |
Why?
|
| Child | 9 | 2026 | 4633 | 0.200 |
Why?
|
| Alleles | 5 | 2026 | 455 | 0.200 |
Why?
|
| Syndrome | 2 | 2021 | 180 | 0.200 |
Why?
|
| Fingers | 1 | 2023 | 49 | 0.200 |
Why?
|
| Adult | 7 | 2025 | 17508 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2021 | 395 | 0.180 |
Why?
|
| CDX2 Transcription Factor | 1 | 2021 | 5 | 0.180 |
Why?
|
| Sacrococcygeal Region | 1 | 2021 | 8 | 0.180 |
Why?
|
| Muscle Spasticity | 1 | 2021 | 4 | 0.180 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 21 | 0.170 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 21 | 0.170 |
Why?
|
| Glucose-6-Phosphate | 1 | 2021 | 2 | 0.170 |
Why?
|
| Phosphotransferases | 1 | 2021 | 22 | 0.170 |
Why?
|
| Hypertrichosis | 1 | 2021 | 5 | 0.170 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 6 | 0.170 |
Why?
|
| Microcephaly | 1 | 2021 | 15 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 37 | 0.170 |
Why?
|
| Growth Disorders | 1 | 2021 | 30 | 0.170 |
Why?
|
| Male | 13 | 2026 | 31285 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2021 | 45 | 0.170 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 2 | 0.160 |
Why?
|
| Hearing Loss | 1 | 2021 | 55 | 0.160 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2020 | 8 | 0.160 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2020 | 7 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2015 | 190 | 0.160 |
Why?
|
| Epilepsy | 1 | 2021 | 113 | 0.160 |
Why?
|
| Leukemoid Reaction | 1 | 2020 | 4 | 0.160 |
Why?
|
| Pedigree | 3 | 2026 | 193 | 0.160 |
Why?
|
| Twins, Monozygotic | 1 | 2020 | 73 | 0.150 |
Why?
|
| Diseases in Twins | 1 | 2020 | 56 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2026 | 925 | 0.150 |
Why?
|
| Adolescent | 7 | 2026 | 6349 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2020 | 47 | 0.150 |
Why?
|
| Young Adult | 4 | 2023 | 4855 | 0.150 |
Why?
|
| Hypokalemia | 1 | 2019 | 13 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2025 | 929 | 0.140 |
Why?
|
| Dependovirus | 1 | 2025 | 760 | 0.140 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2018 | 3 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2025 | 852 | 0.130 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 41 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 25 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2016 | 129 | 0.120 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 70 | 0.120 |
Why?
|
| Noonan Syndrome | 1 | 2015 | 2 | 0.120 |
Why?
|
| Neurofibromin 1 | 1 | 2015 | 14 | 0.110 |
Why?
|
| Codon | 1 | 2015 | 60 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 238 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 364 | 0.110 |
Why?
|
| Bottle Feeding | 1 | 2014 | 6 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2014 | 50 | 0.100 |
Why?
|
| Hypertension | 1 | 2019 | 616 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2011 | 122 | 0.100 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2011 | 12 | 0.090 |
Why?
|
| Serologic Tests | 1 | 2011 | 34 | 0.090 |
Why?
|
| Cross Reactions | 1 | 2011 | 140 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 992 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2014 | 337 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2011 | 208 | 0.080 |
Why?
|
| Glycosylation | 2 | 2021 | 139 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 1559 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 708 | 0.070 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2026 | 4 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 198 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 20 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2026 | 177 | 0.050 |
Why?
|
| Protein Transport | 1 | 2026 | 405 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2026 | 119 | 0.050 |
Why?
|
| Risk Factors | 1 | 2014 | 5466 | 0.050 |
Why?
|
| Intestines | 1 | 2005 | 184 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2005 | 222 | 0.050 |
Why?
|
| Zebrafish | 1 | 2026 | 374 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2021 | 7 | 0.040 |
Why?
|
| Age of Onset | 1 | 2021 | 174 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2021 | 4 | 0.040 |
Why?
|
| Constipation | 1 | 2021 | 15 | 0.040 |
Why?
|
| Diet, Ketogenic | 1 | 2020 | 1 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2021 | 143 | 0.040 |
Why?
|
| Transferrin | 1 | 2020 | 70 | 0.040 |
Why?
|
| Mineralocorticoids | 1 | 2019 | 2 | 0.040 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2019 | 91 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2019 | 117 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6948 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 9 | 0.030 |
Why?
|
| Global Health | 1 | 2019 | 181 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 21 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 1996 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2019 | 192 | 0.030 |
Why?
|
| Dwarfism | 1 | 2015 | 16 | 0.030 |
Why?
|
| Animals | 2 | 2026 | 21450 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 517 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 933 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1487 | 0.030 |
Why?
|
| Middle Aged | 2 | 2015 | 18434 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 2639 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2005 | 48 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2005 | 147 | 0.010 |
Why?
|